Iophendylate

Summary

Iophendylate (CHEMBL951) is an approved small molecule (ATC V08AD04).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: V08AD04
• Chemistry: 416.3 Da · C19H29IO2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL951
Name	Iophendylate
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	7458
ATC	V08AD04
Molecular formula	C19H29IO2
Molecular weight	416.3
InChIKey	LAYLQVBQIBQVLL-UHFFFAOYSA-N

SMILES: CCOC(=O)CCCCCCCCC(C)C1=CC=C(C=C1)I

IUPAC name: ethyl 10-(4-iodophenyl)undecanoate

Also known as: Iofendilato, Iofendylate, Iophendylate, Pantopaque, IOPHENDYLATE

Patent coverage: 271 distinct patent families (790 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).